Document:

Exhibit 10.1

 

EMPLOYMENT AGREEMENT

 

THIS EMPLOYMENT AGREEMENT (this “Agreement”) is
entered into by and between Conatus Pharmaceuticals Inc., a Delaware corporation (the “Company”), and Michelle
L. Vandertie (“Employee”), and shall be effective as of March 24, 2016 (the “Effective Date”).

 

WHEREAS, the Company desires to continue to employ Employee, and
Employee desires to continue employment with the Company, on the terms and conditions set forth in this Agreement.

 

NOW, THEREFORE, in consideration of the mutual promises herein contained,
the parties agree as follows:

 

1.                 
Definitions. As used in this Agreement, the following terms shall have the following meanings:

 

(a)       Board. “Board”
means the Board of Directors of the Company.

 

(b)       Cause. “Cause”
means any of the following:

 

(i)        the commission of an
act of fraud, embezzlement or dishonesty by Employee that has a material adverse impact on the Company or any successor or affiliate
thereof;

 

(ii)        a conviction of, or
plea of “guilty” or “no contest” to, a felony by Employee or any crime involving fraud, misappropriation,
embezzlement or moral turpitude;

 

(iii)        any unauthorized
use or disclosure by Employee of confidential information or trade secrets of the Company or any successor or affiliate thereof
that has a material adverse impact on any such entity;

 

(iv)        Employee’s
gross negligence, insubordination or material violation of any duty of loyalty to the Company or any other material misconduct
on the part of Employee;

 

(v)       Employee’s
ongoing and repeated failure or refusal to perform or neglect of Employee’s duties as required by this Agreement, which failure,
refusal or neglect continues for fifteen (15) days following Employee’s receipt of written notice from the Board or the Company’s
Chief Executive Officer (the “CEO”) stating with specificity the nature of such failure, refusal or neglect;
or

 

(vi)        Employee’s breach
of any material provision of this Agreement;

 

provided, however, that prior to the determination that “Cause”
under this Section 1(b) has occurred, the Company shall (w) provide to Employee in writing, in reasonable detail, the reasons for
the determination that such “Cause” exists, (x) other than with respect to clause (v) above which specifies the applicable
period of time for Employee to remedy his or her breach, afford Employee a reasonable opportunity to remedy any such breach (if
such breach is capable of being remedied), (y) provide Employee an opportunity to be heard prior to the final decision to terminate
Employee’s employment hereunder for such “Cause” and (z) make any decision that such “Cause” exists
in good faith.

 

     

     

    

The foregoing definition shall not in any way preclude or restrict
the right of the Company or any successor or affiliate thereof to discharge or dismiss Employee for any other acts or omissions,
but such other acts or omissions shall not be deemed, for purposes of this Agreement, to constitute grounds for termination for
Cause.

 

(c)       Change of Control.
“Change of Control” means and includes each of the following:

 

(i)a transaction or series of transactions (other than an offering
of common stock of the Company to the general public through a registration statement filed with the Securities and Exchange Commission)
whereby any “person” or related “group” of “persons” (as such terms are used in Sections 13(d)
and 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules thereunder)
(other than the Company, any of its subsidiaries, an employee benefit plan maintained by the Company or any of its subsidiaries
or a “person” that, prior to such transaction, directly or indirectly controls, is controlled by, or is under common
control with, the Company) directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 under the Exchange
Act) of securities of the Company possessing more than fifty percent (50%) of the total combined voting power of the Company’s
securities outstanding immediately after such acquisition; or

 

(ii)during any period of two consecutive years, individuals
who, at the beginning of such period, constitute the Board together with any new director(s) (other than a director designated
by a person who shall have entered into an agreement with the Company to effect a transaction described in subsections (i) or
(iii) of this Section 1(c)) whose election by the Board or nomination for election by the Company’s stockholders was
approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the
two year period or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority
thereof; or

 

(iii)the consummation by the Company (whether directly involving
the Company or indirectly involving the Company through one or more intermediaries) of a merger, consolidation, reorganization,
or business combination, a sale or other disposition of all or substantially all of the Company’s assets, or the acquisition
of assets or stock of another entity, in each case, other than a transaction

 

(A)which results in the Company’s voting securities outstanding
immediately before the transaction continuing to represent (either by remaining outstanding or by being converted into voting securities
of the Company or the person that, as a result of the transaction, controls, directly or indirectly, the Company or owns, directly
or indirectly, all or substantially all of the Company’s assets or otherwise succeeds to the business of the Company (the
Company or such person, the “Successor Entity”)) directly or indirectly, at least fifty percent (50%) of the
combined voting power of the Successor Entity’s outstanding voting securities immediately after the transaction, and

 

    	 	2	 

     

    

(B)after which no person or group beneficially owns voting
securities representing fifty percent (50%) or more of the combined voting power of the Successor Entity; provided, however,
that no person or group shall be treated for purposes of this subsection (iii) as beneficially owning fifty percent (50%) or more
of combined voting power of the Successor Entity solely as a result of the voting power held in the Company prior to the consummation
of the transaction; or

 

(iv)the Company’s stockholders approve a liquidation
or dissolution of the Company.

 

For purposes of subsection (i) above, the calculation of voting power
shall be made as if the date of the acquisition were a record date for a vote of the Company’s stockholders, and for purposes
of subsection (iii) above, the calculation of voting power shall be made as if the date of the consummation of the transaction
were a record date for a vote of the Company’s stockholders.

 

Notwithstanding the foregoing, a transaction shall not constitute
a “Change of Control” if: (i) its sole purpose is to change the state of the Company’s incorporation;
(ii) its sole purpose is to create a holding company that will be owned in substantially the same proportions by the persons who
held the Company’s securities immediately before such transaction; (iii) it constitutes the Company’s initial public
offering of its securities; or (iv) it is a transaction effected primarily for the purpose of financing the Company with cash
(as determined by the Board in its discretion and without regard to whether such transaction is effectuated by a merger, equity
financing or otherwise).

 

(d)       Code. “Code”
means the Internal Revenue Code of 1986, as amended from time to time, and the Treasury Regulations and other guidance issued thereunder.

 

(e)       Good Reason. Employee’s
resignation for “Good Reason” means Employee’s resignation following the occurrence of any of the following
events or conditions without Employee’s written consent:

 

(i)a material diminution in Employee’s
authority, duties or responsibilities;

 

(ii)a material diminution in Employee’s
base compensation, except in connection with a general reduction in the base compensation of the Company’s or any successor’s
or affiliate’s personnel with similar status and responsibilities;

 

(iii)a material change in the geographic
location at which Employee must perform his or her duties (and the Company and Employee agree that any requirement that Employee
be based at any place outside a 50-mile radius of his or her place of employment as of the Effective Date, except for reasonably
required travel on the Company’s or any successor’s or affiliate’s business that is not materially greater than
such travel requirements prior to the Effective Date, shall be considered a material change); or

 

(iv)any other action or inaction that constitutes
a material breach by the Company or any successor or affiliate of its obligations to Employee under this Agreement.

 

    	 	3	 

     

    

Notwithstanding the foregoing, Good Reason shall only exist
if Employee shall have provided the Company with written notice within ninety (90) days of the initial occurrence of any of the
foregoing events or conditions, and the Company or any successor or affiliate fails to eliminate the conditions constituting Good
Reason within thirty (30) days after receipt of written notice of such event or condition from Employee. Employee’s termination
by reason of resignation from employment with the Company for Good Reason shall be treated as involuntary. Employee’s resignation
from employment with the Company for “Good Reason” must occur within twelve (12) months following the initial occurrence
of one of the foregoing events or conditions.

 

(f)Permanent Disability. Employee’s “Permanent
Disability” shall be deemed to have occurred if Employee shall become physically or mentally incapacitated or disabled
or otherwise unable fully to discharge his or her duties hereunder for a period of ninety (90) consecutive calendar days or for
one hundred twenty (120) calendar days in any one hundred eighty (180) calendar-day period. The existence of Employee’s Permanent
Disability shall be determined by the Company on the advice of a physician chosen by the Company and the Company reserves the right
to have the Employee examined by a physician chosen by the Company at the Company’s expense.

 

(g)       Stock Awards. “Stock
Awards” means all stock options, restricted stock and such other awards granted pursuant to the Company’s stock
option and equity incentive award plans or agreements and any shares of stock issued upon exercise thereof.

 

2.                 
Employment Period. During the term of Employee’s employment hereunder (the “Employment Period”),
Employee shall be considered an employee of the Company. The Company and Employee acknowledge that Employee’s employment
during the Employment Period will be at-will, as defined under applicable law, and that Employee’s employment with the Company
during the Employment Period may be terminated by either party at any time for any or no reason, with or without notice. If Employee’s
employment during the Employment Period terminates for any reason, Employee shall not be entitled to any payments, benefits, damages,
awards or compensation other than as provided in this Agreement.

 

3.                 
Services to Be Rendered.

 

(a)Duties and Responsibilities. Employee shall serve
as Vice President, Finance, of the Company. In the performance of such duties, Employee shall report directly to the Chief Financial
Officer (the "Supervising Officer"), and shall be subject to the direction of the Supervising Officer and to such
limits upon Employee’s authority as the Supervising Officer may from time to time impose. In the event of the Supervising
Officer’s incapacity or unavailability, Employee shall be subject to the direction of the CEO or the Board or its designee.
Employee hereby consents to serve as an officer and/or director of the Company or any subsidiary or affiliate thereof without any
additional salary or compensation, if so requested by the Board, the CEO or the Supervising Officer. Employee’s primary place
of work shall be the Company’s facility in San Diego, California, or such other location within San Diego County as may be
designated by the Board, the CEO or the Supervising Officer from time to time. Employee shall also render services at such other
places within or outside the United States as the Board, the CEO or the Supervising Officer may direct from time to time. Employee
shall be subject to and comply with the policies and procedures generally applicable to employees of the Company to the extent
the same are not inconsistent with any term of this Agreement.

 

    	 	4	 

     

    

(b)Exclusive Services. Employee shall be employed
by the Company on a full-time basis. Employee shall at all times faithfully, industriously and to the best of his or her ability,
experience and talent perform to the satisfaction of the Supervising Officer all of the duties that may be assigned to Employee
hereunder and shall devote substantially all of his or her productive time and efforts to the performance of such duties.

 

4.      Compensation and Benefits During
Employment Period. During the Employment Period, the Company shall pay or provide, as the case may be, to Employee the compensation
and other benefits and rights set forth in this Section 4.

 

(a)       Base Salary. The
Company shall pay to Employee a base salary of $237,317 per year, payable in accordance with the Company’s usual pay practices
(and in any event no less frequently than bi-monthly). Employee’s base salary shall be subject to review annually by and
at the sole discretion of the Board or its designee.

 

(b)       Annual Bonus. Employee
shall be eligible to earn, for each fiscal year of the Company ending during the Employment Period, an annual cash performance
bonus (an “Annual Bonus”) based on Employee’s and/or the Company’s attainment of objective financial
or other operating criteria established by the Board or its designee. Upon full attainment of the aforementioned criteria, as determined
by the Board or its designee, the Annual Bonus will be equal to thirty percent (30%) of Employee’s then-current base salary
actually paid for such fiscal year. The Annual Bonus shall be paid to Employee by the Company between January 1st and
March 15th of the calendar year following the end of the fiscal year to which such Annual Bonus relates. Employee’s
receipt of an Annual Bonus shall be conditioned on Employee’s continued employment with the Company on the date such Annual
Bonus is paid. The Annual Bonus shall be pro-rated for any partial fiscal year during the Employment Period. As of the Effective
Date, the Company’s fiscal year ends on December 31. In the event of any change to the Company’s fiscal year, the aforementioned
financial or other operating criteria established by the Board or its designee for purposes of determining Employee’s Annual
Bonus shall be adjusted in a manner mutually agreeable to the Company and Employee so as not to disadvantage either party.

 

(c)       Benefits. Employee
shall be entitled to participate in benefits under the Company’s benefit plans and arrangements, including, without limitation,
any employee benefit plan or arrangement made available in the future by the Company to its employees, subject to and on a basis
consistent with the terms, conditions and overall administration of such plans and arrangements. The Company shall have the right
to amend or delete any such benefit plan or arrangement made available by the Company to its employees and not otherwise specifically
provided for herein. The Company’s failure to continue provide Employee with benefits substantially equivalent (in terms
of benefit levels and/or reward opportunities) to those provided to Employee under each material employee benefit plan, program
and practice of the Company as in effect immediately prior to the Effective Date, except in connection with a general reduction
in the benefits of the Company’s or any successor’s or affiliate’s personnel with similar status and responsibilities,
shall constitute a material breach of this Agreement by the Company.

 

    	 	5	 

     

    

(d)       Expenses. The Company
shall reimburse Employee for reasonable out-of-pocket business expenses incurred in connection with the performance of his or her
duties hereunder, subject to (i) such policies as the Company may from time to time establish, (ii) Employee furnishing
the Company with evidence in the form of receipts satisfactory to the Company substantiating the claimed expenditures, (iii) Employee
receiving advance approval from the CEO in the case of expenses for travel outside of North America, and (iv) Employee receiving
advance approval from the CEO in the case of expenses (or a series of related expenses) in excess of $10,000. Any amounts payable
under this Section 4(d) shall be made in accordance with Treasury Regulation Section 1.409A-3(i)(1)(iv) and shall be paid on or
before the last day of Employee’s taxable year following the taxable year in which Employee incurred the expenses. The amounts
provided under this Section 4(d) during any taxable year of Employee’s will not affect such amounts provided in any other
taxable year of Employee’s, and Employee’s right to reimbursement for such amounts shall not be subject to liquidation
or exchange for any other benefit.

 

(e)       Paid Time Off; Vacation.
Employee shall be entitled to such periods of paid time off (“PTO”) each year as provided under the Company’s
PTO policy and as otherwise provided for similarly-situated employees.

 

(f)       Stock Awards.

 

(i)       As soon as practicable
following the Effective Date and subject to approval by the Board or its Compensation Committee, Employee will be granted a stock
option under the Company’s 2013 Incentive Award Plan (the “Plan”) to purchase 20,000 shares of the Company’s
common stock, with an exercise price per share equal to the per share fair market value of the Company’s common stock on
the date of grant as determined under the Plan (the “Initial Option”). The Initial Option will vest with respect to
twenty-five percent (25%) of the total number of shares of the Company's common stock subject to the Initial Option on the first
anniversary of the Effective Date, and with respect to one-forty-eighth (1/48) of the total number of shares of the Company's common
stock subject to the Initial Option on the last day of each one-month period of Employee's service to the Company thereafter, subject
to accelerated vesting as provided in Section 4(g) below. The Initial Option will be subject to the terms and conditions of the
Plan and the form of stock option agreement thereunder.

 

(ii)       Employee shall
be entitled to participate in any equity or other employee benefit plan that is generally available to employees of the Company.
Except as otherwise provided in this Agreement, Employee’s participation in and benefits under any such plan shall be on
the terms and subject to the conditions specified in the governing document of the particular plan.

 

(g)       Acceleration
of Vesting of Stock Awards.

 

(i)       In the event
of a Change of Control, the vesting and/or exercisability of each of Employee's outstanding Stock Awards shall be automatically
accelerated on the date of such Change of Control as to the number of Stock Awards that would vest over the twenty-four (24) month
period following the date of such Change of Control pursuant to the vesting schedule(s) applicable to such Stock Awards.

 

    	 	6	 

     

    

(ii)       Subject to
Section 5(c), if Employee’s employment is terminated by the Company without Cause or by Employee for Good Reason, the vesting
and/or exercisability of each of Employee’s outstanding Stock Awards shall be automatically accelerated on the date of termination
as to the number of Stock Awards that would vest over the six (6) month period following the date of termination had Employee remained
continuously employed by the Company during such period.

 

(iii)       The foregoing
provisions are hereby deemed to be a part of each Stock Award and to supersede any less favorable provision in any agreement or
plan regarding such Stock Award.

 

5.       Termination of Employment
Period and Severance. Employee shall be entitled to receive benefits upon termination of the Employment Period only as set
forth in this Section 5.

 

(a)       Termination Without
Cause or For Good Reason. If Employee’s employment is terminated by the Company without Cause or by Employee for Good
Reason, Employee shall be entitled to receive, in lieu of any severance benefits to which Employee may otherwise be entitled under
any severance plan or program of the Company, the benefits provided below:

 

(i)the Company shall pay to Employee his or her
fully earned but unpaid base salary, when due, through the date of termination at the rate then in effect, accrued but unused PTO,
plus all other amounts or benefits to which Employee is entitled under any compensation, retirement or benefit plan or practice
of the Company at the time of termination in accordance with the terms of such plans or practices;

 

(ii)subject to Sections 5(c), 5(g) and 5(h) and
Employee’s continuing compliance with Section 6, Employee shall be entitled to receive Employee’s monthly base salary
as in effect immediately prior to the date of termination for the six (6) month period following the date of termination, payable
in a lump sum no later than sixty (60) days following the date of Employee’s termination of employment; and

 

(iii)subject to Sections 5(c), 5(g) and 5(h) and
Employee’s continuing compliance with Section 6, for the period beginning on the date of termination and ending on the date
which is six (6) full months following the date of termination (or, if earlier, the date on which the applicable continuation period
under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”) expires) (the “COBRA
Coverage Period”), the Company shall pay for and provide to Employee and his or her eligible dependents who were covered
under the Company’s health insurance plans immediately prior to the date of termination with healthcare insurance benefits
substantially similar to those provided to Employee and his or her eligible dependents immediately prior to the date of termination.
If any of the Company’s health benefits are self-funded as of the date of termination, or if the Company cannot provide the
foregoing benefits in a manner that is exempt from or otherwise compliant with applicable law (including, without limitation, Section
409A of the Code and Section 2716 of the Public Health Service Act), instead of providing continued health insurance benefits as
set forth above, the Company shall instead pay to Employee an amount equal to the monthly plan premium payment for Employee and
his or her eligible dependents who were covered under the Company’s health plans as of the date of termination (calculated
by reference to Employee’s premiums as of the date of termination) as currently taxable compensation in substantially equal
monthly installments over the COBRA Coverage Period (or the remaining portion thereof).

 

    	 	7	 

     

    

(b)Termination for Cause,
Voluntary Resignation Without Good Reason, Death or Permanent Disability. If Employee’s employment is terminated by the
Company for Cause, by Employee without Good Reason or as a result of Employee’s death or Permanent Disability, the Company
shall not have any other or further obligations to Employee (or his or her estate) under this Agreement (including any financial
obligations) except that Employee (or his or her estate) shall be entitled to receive (i) Employee’s fully earned but unpaid
base salary, through the date of termination at the rate then in effect, (ii) all accrued but unused PTO, and (iii) all other amounts
or benefits to which Employee is entitled under any compensation, retirement or benefit plan or practice of the Company at the
time of termination in accordance with the terms of such plans or practices, including, without limitation, any continuation of
benefits required by COBRA or applicable law. In addition, if Employee’s employment is terminated by the Company for Cause,
by Employee without Good Reason or as a result of Employee’s death or Permanent Disability, all vesting of Employee’s
unvested Stock Awards previously granted to him or her by the Company shall cease and none of such unvested Stock Awards shall
be exercisable following the date of such termination. The foregoing shall be in addition to, and not in lieu of, any and all other
rights and remedies which may be available to the Company under the circumstances, whether at law or in equity.

 

(c)       Release. As a condition
to Employee’s receipt of any post-termination benefits pursuant to Sections 4(g)(i), 4(g)(ii) or 5(a) above, on or prior
to the sixtieth (60th) day following the date of Employee’s termination of employment, Employee shall have executed
and delivered a Release (the “Release”) in a form reasonably acceptable to the Company and any applicable revocation
period applicable to such Release shall have expired. Such Release shall specifically relate to all of Employee’s rights
and claims in existence at the time of such execution, including any claims related to Employee’s employment by the Company
and his or her termination of employment, and shall exclude any continuing obligations the Company may have to Employee following
the date of termination under this Agreement or any other agreement providing for obligations to survive Employee’s termination
of employment. In the event the Release does not become effective within the sixty (60) day period following the date of Employee's
termination of employment, Employee shall not be entitled to any of the aforesaid post-termination benefits.

 

(d)       Exclusive
Remedy. Except as otherwise expressly required by law (e.g., COBRA) or as specifically provided herein, all of Employee’s
rights to salary, severance, benefits, bonuses and other amounts hereunder (if any) accruing after the termination of Employee’s
employment shall cease upon such termination. In the event of a termination of Employee’s employment with the Company, Employee’s
sole remedy shall be to receive the payments and benefits described in this Section 5. In addition, Employee acknowledges and agrees
that he or she is not entitled to any reimbursement by the Company for any taxes payable by Employee as a result of the payments
and benefits received by Employee pursuant to this Section 5, including, without limitation, any excise tax imposed by Section
4999 of the Code. Any payments made to Employee under this Section 5 shall be inclusive of any amounts or benefits to which Employee
may be entitled pursuant to the Worker Adjustment and Retraining Notification Act, 29 U.S.C. Sections 2101 et seq., and the Department
of Labor regulations thereunder, or any similar state statute.

 

    	 	8	 

     

    

(e)       No
Mitigation. Employee shall not be required to mitigate the amount of any payment provided for in this Section 5 by seeking
other employment or otherwise, nor shall the amount of any payment or benefit provided for in this Section 5 be reduced by any
compensation earned by Employee as the result of employment by another employer or self-employment or by retirement benefits; provided,
however, that loans, advances or other amounts owed by Employee to the Company may be offset by the Company against amounts
payable to Employee under this Section 5; provided, further, that, as provided in Section 5(a), Employee’s
right to continued healthcare and life insurance benefits following his or her termination of employment will terminate on the
date on which the applicable continuation period under COBRA expires.

 

(f)       Return
of the Company’s Property. If Employee’s employment is terminated for any reason, the Company shall have the right,
at its option, to require Employee to vacate his or her offices prior to or on the effective date of termination and to cease all
activities on the Company’s behalf. Upon the termination of his or her employment in any manner, as a condition to the Employee’s
receipt of any post-termination benefits described in this Agreement, Employee shall immediately surrender to the Company all lists,
books and records of, or in connection with, the Company’s business, and all other property belonging to the Company, it
being distinctly understood that all such lists, books and records, and other documents, are the property of the Company. Employee
shall deliver to the Company a signed statement certifying compliance with this Section 5(f) prior to the receipt of any post-termination
benefits described in this Agreement.

 

(g)Short-Term Deferral.
This Agreement is not intended to provide for any deferral of compensation subject to Section 409A of the Code, and, accordingly,
the severance payment payable under Section 5(a)(ii) shall be paid no later than the later of: (i) the fifteenth (15th)
day of the third month following Employee's first taxable year in which such severance benefit is no longer subject to a substantial
risk of forfeiture, and (ii) the fifteenth (15th) day of the third month following the first taxable year of the Company
in which such severance benefit is no longer subject to a substantial risk of forfeiture, as determined in accordance with Section
409A of the Code and any Treasury Regulations and other guidance issued thereunder. To the extent applicable, this Agreement shall
be interpreted in accordance with the applicable exemptions from Section 409A of the Code.

 

    	 	9	 

     

    

(h)Payment Delay.
Notwithstanding anything herein to the contrary, to the extent any payments to Employee pursuant to Section 5(a)(ii) are treated
as non-qualified deferred compensation subject to Section 409A of the Code, then (i) no amount shall be payable pursuant to such
section unless Employee’s termination of employment constitutes a “separation from service” with the Company
(as such term is defined in Treasury Regulation Section 1.409A-1(h) and any successor provision thereto) (a “Separation
from Service”), and (ii) if Employee, at the time of his or her Separation from Service, is determined by the Company
to be a “specified employee” for purposes of Section 409A(a)(2)(B)(i) of the Code and the Company determines that delayed
commencement of any portion of the termination benefits payable to Employee pursuant to this Agreement is required in order to
avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code (any such delayed commencement, a “Payment
Delay”), then such portion of Employee’s termination benefits described in Section 5(a)(ii) shall not be provided
to Employee prior to the earlier of (A) the expiration of the six-month period measured from the date of Employee’s Separation
from Service, (B) the date of Employee’s death or (C) such earlier date as is permitted under Section 409A. Upon the expiration
of the applicable Code Section 409A(a)(2)(B)(i) deferral period, all payments deferred pursuant to a Payment Delay shall be paid
in a lump sum to Employee within thirty (30) days following such expiration, and any remaining payments due under the Agreement
shall be paid as otherwise provided herein. The determination of whether Employee is a “specified employee” for purposes
of Section 409A(a)(2)(B)(i) of the Code as of the time of his or her Separation from Service shall made by the Company in accordance
with the terms of Section 409A of the Code and applicable guidance thereunder (including without limitation Treasury Regulation
Section 1.409A-1(i) and any successor provision thereto).

 

(i)Interpretation. To the extent the payments and
benefits under this Agreement are subject to Section 409A of the Code, this Agreement shall be interpreted, construed and administered
in a manner that satisfies the requirements of Sections 409A(a)(2), (3) and (4) of the Code and the Treasury Regulations thereunder
(and any applicable transition relief under Section 409A of the Code). To the extent that any provision of this Agreement is ambiguous
as to its compliance with Section 409A of the Code, the provision shall be read in such a manner that no payments payable under
this Agreement shall be subject to an "additional tax" as defined in Section 409A(a)(1)(B) of the Code. Each series of
installment payments made under this Agreement is hereby designated as a series of "separate payments" within the meaning
of Section 409A of the Code.

 

6.       Certain
Covenants.

 

(a)               
Noncompetition. Except as may otherwise be approved by the Board, during the Employment Period, Employee shall not
have any ownership interest (of record or beneficial) in, or perform services as an employee, salesman, consultant, officer or
director of, or otherwise aid or assist in any manner, any firm, corporation, partnership, proprietorship or other business that
engages in any county, city or part thereof in the United States and/or any foreign country in a business which competes directly
or indirectly (as determined by the Board) with the Company’s business in such county, city or part thereof, so long as the
Company, or any successor in interest of the Company to the business and goodwill of the Company, remains engaged in such business
in such county, city or part thereof or continues to solicit customers or potential customers therein; provided, however,
that Employee may own, directly or indirectly, solely as an investment, securities of any entity if Employee (x) is not a controlling
person of, or a member of a group which controls, such entity; or (y) does not, directly or indirectly, own ten percent (10%) or
more of any class of securities of any such entity. Subject to the terms of the Proprietary Information and Inventions Agreement
referred to in Section 6(b), nothing in this Agreement shall preclude Employee from devoting time to personal and family investments
or serving on community and civic boards, or participating in industry associations, provided such activities do not interfere
with his or her duties to the Company, as determined in good faith by the Board, the CEO or the Supervising Officer. Employee agrees
that he or she will not join any boards, other than community and civic boards (which do not interfere with his or her duties to
the Company), without the prior approval of the Board, the CEO or the Supervising Officer.

 

    	 	10	 

     

    

(b)              
Confidential Information. Employee and the Company have entered into the Company’s standard proprietary information
and inventions agreement (the “Proprietary Information and Inventions Agreement”). Employee agrees to perform
each and every obligation of Employee therein contained.

 

(c)               
Solicitation of Employees. Employee shall not during the Employment Period and for the applicable severance period
for which Employee receives severance benefits following any termination hereof pursuant to Section 5(a) above (the “Restricted
Period”), directly or indirectly, solicit or encourage to leave the employment of the Company or any of its affiliates,
any employee of the Company or any of its affiliates.

 

(d)              
Solicitation of Consultants. Employee shall not during the Employment Period and for the Restricted Period, directly
or indirectly, hire, solicit or encourage to cease work with the Company or any of its affiliates any consultant then under contract
with the Company or any of its affiliates within one year of the termination of such consultant’s engagement by the Company
or any of its affiliates.

 

(e)               
Rights and Remedies Upon Breach. If Employee breaches or threatens to commit a breach of any of the provisions of
this Section 6 (the “Restrictive Covenants”), the Company shall have the following rights and remedies,
each of which rights and remedies shall be independent of the other and severally enforceable, and all of which rights and remedies
shall be in addition to, and not in lieu of, any other rights and remedies available to the Company under law or in equity:

 

(i)                
Specific Performance. The right and remedy to have the Restrictive Covenants specifically enforced by any court having
equity jurisdiction, all without the need to post a bond or any other security or to prove any amount of actual damage or that
money damages would not provide an adequate remedy, it being acknowledged and agreed that any such breach or threatened breach
will cause irreparable injury to the Company and that money damages will not provide adequate remedy to the Company;

 

(ii)              
Accounting and Indemnification. The right and remedy to require Employee (i) to account for and pay over to
the Company all compensation, profits, monies, accruals, increments or other benefits derived or received by Employee or any associated
party deriving such benefits as a result of any such breach of the Restrictive Covenants; and (ii) to indemnify the Company
against any other losses, damages (including special and consequential damages), costs and expenses, including actual attorneys’
fees and court costs, which may be incurred by them and which result from or arise out of any such breach or threatened breach
of the Restrictive Covenants; and

 

    	 	11	 

     

    

(iii)            
Termination of Severance Payments. In the event Employee breaches any of the provisions of this Section 6, the Company
shall be entitled to immediately cease all payments under Section 5(a) above.

 

(f)       Severability
of Covenants/Blue Pencilling. If any court determines that any of the Restrictive Covenants, or any part thereof, is invalid
or unenforceable, the remainder of the Restrictive Covenants shall not thereby be affected and shall be given full effect, without
regard to the invalid portions. If any court determines that any of the Restrictive Covenants, or any part thereof, are unenforceable
because of the duration of such provision or the area covered thereby, such court shall have the power to reduce the duration or
area of such provision and, in its reduced form, such provision shall then be enforceable and shall be enforced. Employee hereby
waives any and all right to attack the validity of the Restrictive Covenants on the grounds of the breadth of their geographic
scope or the length of their term.

 

(g)       Enforceability
in Jurisdictions. The Company and Employee intend to and do hereby confer jurisdiction to enforce the Restrictive Covenants
upon the courts of any jurisdiction within the geographical scope of such covenants. If the courts of any one or more of such jurisdictions
hold the Restrictive Covenants wholly unenforceable by reason of the breadth of such scope or otherwise, it is the intention of
the Company and Employee that such determination not bar or in any way affect the right of the Company to the relief provided above
in the courts of any other jurisdiction within the geographical scope of such covenants, as to breaches of such covenants in such
other respective jurisdictions, such covenants as they relate to each jurisdiction being, for this purpose, severable into diverse
and independent covenants.

 

(h)       Whistleblower
Provision. Nothing herein shall be construed to prohibit Employee from communicating directly with, cooperating with, or providing
information to, any government regulator, including, but not limited to, the U.S. Securities and Exchange Commission, the U.S.
Commodity Futures Trading Commission, or the U.S. Department of Justice.

 

(i)       Definitions.
For purposes of this Section 6, the term “Company” means not only Conatus Pharmaceuticals Inc., but also any
company, partnership or entity which, directly or indirectly, controls, is controlled by or is under common control with Conatus
Pharmaceuticals Inc.

 

7.       Insurance. The
Company shall have the right to take out life, health, accident, “key-man” or other insurance covering Employee, in
the name of the Company and at the Company’s expense in any amount deemed appropriate by the Company. Employee shall assist
the Company in obtaining such insurance, including, without limitation, submitting to any required examinations and providing information
and data required by insurance companies.

 

    	 	12	 

     

    

8.       Arbitration.
Any dispute, claim or controversy based on, arising out of or relating to this Agreement, or the breach thereof, including questions
regarding the arbitrability of a particular dispute, shall be settled by final and binding arbitration in San Diego, California,
before a single neutral arbitrator in accordance with the National Rules for the Resolution of Employment Disputes (the “Rules”)
of the American Arbitration Association, and judgment on the award rendered by the arbitrator may be entered in any court having
jurisdiction. The Rules may be found online at www.adr.org. Arbitration may be compelled pursuant to the California Arbitration
Act (Code of Civil Procedure §§ 1280 et seq.). If the parties are unable to agree upon an arbitrator, one shall
be appointed by the AAA in accordance with its Rules. Each party shall pay the fees of its own attorneys, the expenses of its
witnesses and all other expenses connected with presenting its case; however, Employee and the Company agree that, to the
extent permitted by law, the arbitrator may, in his or her discretion, award reasonable attorneys’ fees to the prevailing
party; provided, further, that the prevailing party shall be reimbursed for such fees, costs and expenses within
forty-five (45) days following any such award; provided, further, that the parties’ obligations pursuant to the provisos
set forth above shall terminate on the tenth (10th) anniversary of the date of Employee’s termination of employment. Other
costs of the arbitration, including the cost of any record or transcripts of the arbitration, AAA’s administrative fees,
the fee of the arbitrator, and all other fees and costs, shall be borne by the Company. This Section 8 is intended to be the exclusive
method for resolving any and all claims by the parties against each other for payment of damages under this Agreement, or relating
to Employee's employment; provided, however, that Employee shall retain the right to file administrative charges
with or seek relief through any government agency of competent jurisdiction, and to participate in any government investigation,
including but not limited to (i) claims for workers’ compensation, state disability insurance or unemployment insurance;
(ii) claims for unpaid wages or waiting time penalties brought before the California Division of Labor Standards Enforcement;
provided, however, that any appeal from an award or from denial of an award of wages and/or waiting time penalties
shall be arbitrated pursuant to the terms of this Agreement; and (iii) claims for administrative relief from the United States
Equal Employment Opportunity Commission and/or the California Department of Fair Employment and Housing (or any similar agency
in any applicable jurisdiction other than California); provided, further, that Employee shall not be entitled to
obtain any monetary relief through such agencies other than workers’ compensation benefits or unemployment insurance benefits.
This Agreement shall not limit either party’s right to obtain any provisional remedy, including, without limitation, injunctive
or similar relief, from any court of competent jurisdiction as may be necessary to protect their rights and interests pending
the outcome of arbitration, including without limitation injunctive relief, in any court of competent jurisdiction pursuant to
California Code of Civil Procedure § 1281.8 or any similar statute of an applicable jurisdiction. Seeking any such relief
shall not be deemed to be a waiver of such party’s right to compel arbitration. Both Employee and the Company expressly
waive their right to a jury trial to the extent permitted by applicable law.

 

9.       Miscellaneous.

 

(a)       Modification;
Prior Claims. This Agreement and the Employee Proprietary Information and Inventions Agreement sets forth the entire understanding
of the parties with respect to the subject matter hereof, supersedes all existing agreements between them concerning such subject
matter, including without limitation, any offer letter between Employee and the Company, and may be modified only by a written
instrument duly executed by each party. No oral waiver, amendment or modification will be effective under any circumstances whatsoever.

 

    	 	13	 

     

    

(b)Assignment; Assumption by Successor. The rights
of the Company under this Agreement may, without the consent of Employee, be assigned by the Company, in its sole and unfettered
discretion, to any person, firm, corporation or other business entity which at any time, whether by purchase, merger or otherwise,
directly or indirectly, acquires all or substantially all of the assets or business of the Company. The Company will require any
successor (whether direct or indirect, by purchase, merger or otherwise) to all or substantially all of the business or assets
of the Company expressly to assume and to agree to perform this Agreement in the same manner and to the same extent that the Company
would be required to perform it if no such succession had taken place; provided, however, that no such assumption
shall relieve the Company of its obligations hereunder.  As used in this Agreement, the “Company” shall
mean the Company as hereinbefore defined and any successor to its business and/or assets as aforesaid which assumes and agrees
to perform this Agreement by operation of law or otherwise.

 

(c)       Survival.
The covenants, agreements, representations and warranties contained in or made in Sections 4, 5, 6, 8 and 9 of this Agreement
shall survive any termination of this Agreement.

 

(d)       Third-Party
Beneficiaries. This Agreement does not create, and shall not be construed as creating, any rights enforceable by any person
not a party to this Agreement.

 

(e)       Waiver.
The failure of either party hereto at any time to enforce performance by the other party of any provision of this Agreement shall
in no way affect such party’s rights thereafter to enforce the same, nor shall the waiver by either party of any breach of
any provision hereof be deemed to be a waiver by such party of any other breach of the same or any other provision hereof.

 

(f)       Section
Headings. The headings of the several sections in this Agreement are inserted solely for the convenience of the parties and
are not a part of and are not intended to govern, limit or aid in the construction of any term or provision hereof.

 

(g)       Notices.
All notices, requests and other communications hereunder shall be in writing and shall be delivered by courier or other means of
personal service (including by means of a nationally recognized courier service or professional messenger service), or sent by
telex or telecopy or mailed first class, postage prepaid, by certified mail, return receipt requested, in all cases, addressed
to:

 

If to the Company or the Board:

 

Conatus Pharmaceuticals Inc.

16745 West Bernardo Drive, Suite 200

San Diego, California 92127

Attention: Secretary

 

If to Employee:

 

Michelle L. Vandertie

 

    	 	14	 

     

    

All notices, requests and other communications shall be deemed given on the date of actual
receipt or delivery as evidenced by written receipt, acknowledgement or other evidence of actual receipt or delivery to the address.
In case of service by telecopy, a copy of such notice shall be personally delivered or sent by registered or certified mail, in
the manner set forth above, within three business days thereafter. Any party hereto may from time to time by notice in writing
served as set forth above designate a different address or a different or additional person to which all such notices or communications
thereafter are to be given.

 

(h)       Severability.
All Sections, clauses and covenants contained in this Agreement are severable, and in the event any of them shall be held to be
invalid by any court, this Agreement shall be interpreted as if such invalid Sections, clauses or covenants were not contained
herein.

 

(i)       Governing
Law and Venue. This Agreement is to be governed by and construed in accordance with the laws of the State of California applicable
to contracts made and to be performed wholly within such State, and without regard to the conflicts of laws principles thereof.
Except as provided in Sections 6 and 8, any suit brought hereon shall be brought in the state or federal courts sitting in
San Diego, California, the parties hereto hereby waiving any claim or defense that such forum is not convenient or proper. Each
party hereby agrees that any such court shall have in personam jurisdiction over it and consents to service of process in any manner
authorized by California law.

 

(j)       Non-transferability
of Interest. None of the rights of Employee to receive any form of compensation payable pursuant to this Agreement shall be
assignable or transferable except through a testamentary disposition or by the laws of descent and distribution upon the death
of Employee. Any attempted assignment, transfer, conveyance, or other disposition (other than as aforesaid) of any interest in
the rights of Employee to receive any form of compensation to be made by the Company pursuant to this Agreement shall be void.

 

(k)       Gender.
Where the context so requires, the use of the masculine gender shall include the feminine and/or neuter genders and the singular
shall include the plural, and vice versa, and the word “person” shall include any corporation, firm, partnership or
other form of association.

 

(l)       Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same Agreement.

 

(m)       Construction.
The language in all parts of this Agreement shall in all cases be construed simply, according to its fair meaning, and not strictly
for or against any of the parties hereto. Without limitation, there shall be no presumption against any party on the ground that
such party was responsible for drafting this Agreement or any part thereof.

 

(n)       Withholding
and other Deductions. All compensation payable to Employee hereunder shall be subject to such deductions as the Company is
from time to time required to make pursuant to law, governmental regulation or order.

 

    	 	15	 

     

    

IN WITNESS WHEREOF, the parties have executed this Agreement as of
the date first set forth above.

 

CONATUS PHARMACEUTICALS INC.

 

 

 

By: /s/ Steven J. Mento, Ph.D.

Name: Steven J. Mento, Ph.D.

Title:
President and CEO

 

 

 

/s/ Michelle L. Vandertie

Michelle L. Vandertie

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

16Exhibit 10.1

 

 

March 10, 2017

 

Propanc Health Group Corporation

302/6 Butler Street

Camberwell, VIC, 3124 Australia

Attn: James Nathanielsz

 

 

Re: Maturity Date Extension Agreement

 

Gentlemen:

 

Delafield Investments Limited (“Delafield”)
and Propanc Health Group Corporation (the “Company”) are parties to certain transaction documents (the “Transaction
Documents”), including that certain Securities Purchase Agreement, dated as of October 28, 2015, as amended on March 11,
2016 by an addendum and on July 1, 2016 and August 3, 2016 by separate letter agreements (the “Securities Purchase Agreement”),
and a debenture in the principal amount of $4,400,000 dated October 28, 2015 (as amended, the “Debenture”) and due
on February 28, 2017. Capitalized terms used herein and not defined have the meanings given them in the Securities Purchase Agreement
and the Debenture.

 

By the signature of your authorized representative
below, and for good and valuable consideration, the value and receipt of which is hereby acknowledged, the parties agree as follows:

 

		1.	The Maturity Date shall be extended from February 28, 2017 to September 30, 2017.

		2.	From the period beginning on February 28, 2017 through and including September 30, 2017, the Company shall pay interest to
Delafield on the aggregate unconverted and then outstanding principal amount of the Debenture pursuant to the terms of the Debenture.

		3.	Delafield hereby agrees to waive compliance by the Company with Section 8 of the Debenture regarding payment by the Company
of the outstanding obligations due under the Debenture on February 28, 2017.  This waiver is a one-time waiver only and shall
not be deemed to constitute an agreement by Delafield to waive any other Event of Default which may exist as of the date hereof.

 

Except as expressly set forth herein, all
of the terms and conditions in the Transaction Documents remain unchanged and are in full force and effect.

 

This letter agreement may be executed and
delivered via facsimile or other electronic means with the same force and effect as if an original were executed and may be signed
in any number of counterparts, each of which shall be an original, with the same effect as if the signatures hereto were upon the
same instrument.

 

    
40 Wall Street | New York, NY | 10005
p. 347.491.4240 | f. 646.737.9948

     

    

 

 

 

Please acknowledge your agreement with the
foregoing by executing this letter in the space indicated below and returning the same to the undersigned.

 

	 	Sincerely,
	 	 	 	 
	 	Delafield Investments
    Limited
	 	 	 	 
	 	 	 	 
	 	By:	/s/
    James Keyes
	 	  	Name:	James Keyes
	 	 	Title:   	Director
	 	 	 	 
	 	 	 	 
	 	By:	/s/
    Michael Abitebol
	 	 	Name:	Michael Abitebol
	 	 	Title:   	Director   
	 	 	 	 

 

Acknowledged,
Confirmed and Agreed To:

 

Propanc
Health Group Corporation

 

	By:	/s/ James
    Nathanielsz	 
	 	Name: James Nathanielsz

	 
	 	Title: President and Chief Executive
        Officer

	 

 

 

    
40 Wall Street | New York, NY | 10005
p. 347.491.4240 | f. 646.737.9948

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}]]